Supplementary Data 1 from Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial

Autor:	Virginie Westeel, Gérard Zalcman, Franck Morin, Emilie Charton, Chrystelle Locher, Radj Gervais, Henri Janicot, Valérie Gounant, Isabelle Monnet, Frédéric Rivière, Hervé Léna, Olivier Molinier, Denis Moro-Sibilot, Clarisse Audigier-Valette, Laurent Greillier, Jacques Margery, Julien Mazieres, Arnaud Scherpereel, Amélie Anota, Guillaume Eberst
Rok vydání:	2023
DOI:	10.1158/1078-0432.22474086
Popis:	Table 1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58db821f6b13a94dffd02ca8ab837c49 https://doi.org/10.1158/1078-0432.22474086 Zobrazit plný text záznamu